SetPoint Medical
8 known investors
SetPoint Medical develops an implantable wireless device that stimulates the vagus nerve to reduce inflammation and treat rheumatoid arthritis through a neuroimmune modulation approach. The device is FDA-approved for adults with moderately to severely active rheumatoid arthritis who have inadequate response to biologics or targeted synthetic drugs.
Investors · 8
Catalio Capital Management, LPNew York
Citta CapitalPalo Altovia Jim Mao · inferred
Lightstone VenturesPortola Valley
Norwest Venture PartnersMenlo Park · $10M – $30M
Runway Growth CapitalMenlo Park · $10M – $150M
ShangBay Capital LLCPalo Alto
Action Potential Venture Capital Ltd.reportedScotts Valleyvia Juan-Pablo Mas · board
Cadence Healthcare VenturesreportedHayward